flubromazolam
Selected indexed studies
- Flubromazolam: Detection in five post-mortem cases. (Med Sci Law, 2020) [PMID:32838670]
- Driving Impairment Cases Involving Etizolam and Flubromazolam. (J Anal Toxicol, 2021) [PMID:32399568]
- Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam. (J Anal Toxicol, 2021) [PMID:33048135]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Driving Impairment Cases Involving Etizolam and Flubromazolam. (2021) pubmed
- Flubromazolam: Detection in five post-mortem cases. (2020) pubmed
- Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam. (2021) pubmed
- Designer benzodiazepine rat pharmacokinetics: A comparison of alprazolam, flualprazolam and flubromazolam. (2023) pubmed
- Flubromazolam--A new life-threatening designer benzodiazepine. (2016) pubmed
- Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United Kingdom. (2022) pubmed
- Flualprazolam and flubromazolam: Blood concentrations and prevalence of two novel psychoactive substances in forensic case work in Ontario, Canada. (2023) pubmed
- Flubromazolam overdose: A review of a new designer benzodiazepine and the role of flumazenil. (2019) pubmed
- Flubromazolam - Basic pharmacokinetic evaluation of a highly potent designer benzodiazepine. (2018) pubmed
- The slippery slope of flubromazolam: Experiences of a novel psychoactive benzodiazepine as discussed on a Swedish online forum. (2017) pubmed